Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
IMNM Immunome
- 11.110
- -0.910-7.57%
Close Dec 18 16:00 ET
693.45MMarket Cap-1.40P/E (TTM)
12.140High10.760Low1.08MVolume12.010Open12.020Pre Close12.29MTurnover2.38%Turnover RatioLossP/E (Static)62.42MShares30.95852wk High3.23P/B502.64MFloat Cap8.97052wk Low--Dividend TTM45.24MShs Float63.780Historical High--Div YieldTTM11.48%Amplitude2.090Historical Low11.424Avg Price1Lot Size
About Immunome Company
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
Company Profile
SymbolIMNM
Company NameImmunome
Listing DateOct 2, 2020
Issue Price12.00
Founded2006
CEODr. Clay B. Siegall,PhD
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address18702 North Creek Parkway,Suite 100
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-610-321-3700
Websitehttp://www.immunome.com
Company Executives
- Name
- Position
- Salary
- Dr. Clay B. Siegall,PhD
- Chief Executive Officer, President and Chairman of the Board
- 14.87M
- Dr. Bruce Turner, M.D.,PhD
- Chief Strategy Officer
- --
- Dr. Jack Higgins, PhD
- Chief Scientific Officer
- 1.84M
- Max Rosett
- Principal Accounting Officer, Executive Vice President, Operations and Interim Chief Financial Officer
- --
- Sandra G. Stoneman
- Chief Legal Officer and General Counsel
- --
- Bob Lechleider
- Chief Medical Officer
- 2.92M
- Kinney Horn
- Chief Business Officer
- --
- Carol A. Schafer
- Director
- --
- Philip Wagenheim
- Director
- 59.23K
- Dr. Sandra M. Swain, M.D.
- Director
- --
- Isaac Barchas, J.D.
- Lead Independent Director
- 296.59K
- James P. Boylan, M.B.A.
- Independent Director
- 294.75K
- Jean-Jacques Bienaime
- Independent Director
- 287.93K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.